Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of fluorinated drug candidates where the bromomethyl group enables further functionalization through nucleophilic substitution. Its structure supports the introduction of fluorine, which can enhance metabolic stability and bioavailability in active pharmaceutical ingredients. Commonly employed in the preparation of selective serotonin reuptake inhibitors and other central nervous system agents. Also utilized in agrochemical synthesis for creating herbicides and fungicides due to its reactivity and ability to link aromatic systems. Frequently applied in research settings for building blocks in medicinal chemistry and radiolabeling studies.